RESMED, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 213.3 USD | +0.79% |
|
-2.43% | +23.97% |
ETFs positioned on ResMed, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.10% | 6 M€ | +17.98% | - | |
| 0.10% | 121 M€ | +8.46% | - | |
| 0.09% | 2,517 M€ | +13.18% | - | |
| 0.09% | 57 M€ | +22.25% | - | |
| 0.08% | 1 M€ | +0.04% | ||
| 0.08% | 273 M€ | -.--% | ||
| 0.08% | 655 M€ | -.--% | - | |
| 0.08% | 1,174 M€ | +23.54% | ||
| 0.07% | 234 M€ | +9.05% | - | |
| 0.07% | 375 M€ | +8.78% | ||
| 0.07% | 283 M€ | +21.92% | ||
| 0.07% | 14 M€ | +16.19% | - | |
| 0.06% | 0 M€ | 0.00% | - | |
| 0.06% | 1 M€ | -.--% | ||
| 0.06% | 284 M€ | -.--% | ||
| 0.06% | 571 M€ | +8.06% | - | |
| 0.06% | 34 M€ | +12.43% | - | |
| 0.05% | 23 M€ | -.--% | - | |
| 0.05% | 786 M€ | -.--% | ||
| 0.05% | 206 M€ | -.--% | ||
| 0.05% | 34 M€ | +9.10% | - | |
| 0.05% | 205 M€ | -.--% | ||
| 0.04% | 391 M€ | +9.26% | - | |
| 0.04% | 607 M€ | +0.05% | - | |
| 0.04% | 1,166 M€ | +0.26% | - | |
| 0.04% | 306 M€ | +6.27% | - | |
| 0.04% | 39 M€ | +5.88% | - |
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Calendar
2024-07-31
- Q4 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
213.3
USD
Average target price
216.6
USD
Spread / Average Target
+1.59%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +23.97% | 31.33B | |
| +10.03% | 223B | |
| +13.59% | 195B | |
| +20.01% | 144B | |
| +30.83% | 111B | |
| +2.05% | 65.01B | |
| +15.38% | 53.02B | |
| +3.96% | 50.45B | |
| +8.37% | 44.15B | |
| +3.27% | 36.45B |
- Stock Market
- Equities
- RMD Stock
- Funds and ETFs ResMed, Inc.
